Filter
827
Text search:
dosing
Featured
Recommendations
116
New Publications
224
Language
Document type
No document type
465
Guidelines
181
Studies & Reports
93
Manuals
29
Training Material
21
Fact sheets
16
Strategic & Response Plan
12
Situation Updates
4
Resource Platforms
2
Brochures
1
App
1
Online Courses
1
Videos
1
Countries / Regions
India
46
South Africa
35
Kenya
27
Tanzania
23
Global
19
Ethiopia
17
Zambia
15
Uganda
11
Nepal
10
Africa
10
Sierra Leone
9
Rwanda
9
Western and Central Europe
9
Nigeria
8
Ghana
8
Malawi
8
Namibia
8
Bangladesh
7
Myanmar / Burma
7
Liberia
6
Zimbabwe
6
Philippines
6
West and Central Africa
5
USA
4
Haiti
4
Syria
4
Cambodia
4
Latin America and the Carribbean
4
Congo, Democratic Republic of
3
South Sudan
3
Argentina
3
Eswatini/ Swaziland
3
Lesotho
3
Burkina Faso
2
Germany
2
Indonesia
2
Ukraine
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
United Kingdom
2
Guinea
1
Senegal
1
Mali
1
Guinea-Bissau
1
Cameroon
1
Pakistan
1
Iraq
1
Gambia
1
Sudan
1
Benin
1
Peru
1
Brazil
1
Botswana
1
Angola
1
Yemen
1
East and Southern Africa
1
Middle East and North Africa
1
Venezuela
1
Eastern Europe
1
Albania
1
Canada
1
Timor Leste/ East Timor
1
Tajikistan
1
Russia
1
Georgia
1
North America
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
266
Clinical Guidelines
169
Women & Child Health
49
Public Health
28
Capacity Building
26
Key Resources
19
Pharmacy & Technologies
3
Annual Report MEDBOX
1
Toolboxes
HIV
114
TB
87
AMR
66
COVID-19
42
Pharmacy
36
Mental Health
32
NCDs
22
NTDs
19
Ebola
14
Caregiver
14
Cholera
9
Conflict
8
Rapid Response
7
Refugee
6
Planetary Health
6
Polio
2
Specific Hazards
2
Health Financing Toolbox
2
Disability
1
Natural Hazards
1
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var
...
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect
...
This summary assesses the current state of evidence on each approach in tabular form, providing: the definition and objectives; evidence of effectiveness; operational considerations (e.g., training, staffing, and logistics); cost considerations and evidence on cost-effectiveness; operational success
...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h
...
Updated May 2021
The paper provides the rationale for these recommendations, which are based on analyses of data from the TRACT trial.
Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodborne viruses among patients, health care providers and the community at large.
Guide for clinical case management and infection prevention and control during ameasles outbreak. This guide has been developed to reduce the high morbidity and mortality seen in some of the current outbreaks of measles. This short guide outlines practical clinical care interventions and is derived
...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in
...
The Practical Approach to Care Kit (PACK) is a health systems improvement programme designed to support the work of primary care health workers in underserved communities (like doctors, nurses, midwives, health officers, community health practitioners), strengthen the health services in which they w
...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE
...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti
...
This document is a practical guide to the management of burn injuries for healthcare professionals everyhwere who are non-burn specialistsi
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h
...
This rapid communication outlines the main outcomes of a WHO convened Guideline Development Group (GDG) meeting, held in May-June 2021 on the topic of the management of TB in children and adolescents. The rapid communication aims to inform staff from ministries of health and care providers across p
...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i
...
